India is rapidly expanding access to life‑saving medical implants, but still lacks a National Medical Implant Registry to ensure full traceability, accountability and patient safety. This article by Rajiv Nath (Forum Coordinator, AiMeD) sheds light on why India must urgently build such a system before the next implant‑related crisis finds the country unprepared.
India is advancing rapidly toward the vision of a Viksit Bharat. Our hospitals are modernising, access to advanced treatments is expanding, and more than 10 lakh Indians every year now receive life‑saving implants- cardiac stents, pacemakers, orthopaedic joints, spinal implants, heart valves, neurovascular devices and more. These technologies transform lives and represent the best of medical progress.
Yet, amid this progress lies a critical gap: India still does not have a National Medical Implant Registry.
This means that if a patient asks, “Can the government tell me which implant I received, whether it was recalled abroad, or if others like me faced complications?” – the honest answer today is no.
This is not a minor administrative shortcoming. It is a patient‑safety risk that India can no longer afford.
Why Traceability Matters: The J&J Hip Implant Scandal Must Never Repeat
The Johnson & Johnson ASR metal‑on‑metal hip implant failure remains one of the most painful reminders of what happens when a country lacks traceability.
Globally, the implant showed abnormally high failure rates, releasing metal debris into patients’ bodies, causing severe pain, tissue damage, and the need for repeat surgeries. Countries with implant registries, such as Australia and the UK, quickly detected the unusually high revision rates. They alerted patients, suspended use, and held the manufacturer accountable.
India, however, had no such system.
- Regulators struggled to even determine how many Indians received the implant.
- Patients suffered silently for years, unaware that their symptoms were linked to a global recall.
- Many underwent expensive revision surgeries without compensation.
- The overseas manufacturer faced no meaningful accountability because India had no national record of who was implanted, where, and when.
Patients had to rely on media reports, hospital files, or personal memory to piece together their own medical history. This is not how a modern healthcare system should function.
A National Implant Registry would have allowed India to immediately identify every affected patient, ensure timely follow‑up, and demand responsibility from the manufacturer. The J&J case is not just history; it is a warning.
A Registry Is the Foundation of Patient Safety
A National Implant Registry is a simple but transformative idea:
Every high‑risk implant used in India is digitally recorded and traceable throughout its lifecycle.
Such a system enables:
- Real‑time safety alerts
- Rapid response to global recalls
- Early detection of device failures
- Protection against substandard imports
- Better long‑term outcomes for patients
Countries like the US, UK, Sweden, Germany and Australia have relied on implant registries for decades. India, with its digital capabilities and Ayushman Bharat Digital Mission infrastructure, is more than capable of building a world‑class system.
UDI Is Not Enough: We Need End‑to‑End Traceability
India has already introduced Unique Device Identification (UDI) for medical devices. But UDI alone is only a label. Without a national registry linking UDI to hospitals, surgeons and patients, the system remains incomplete.
When integrated with ABHA IDs, a registry will ensure:
- full traceability,
- secure patient‑level data,
- anonymised analytics, and
- protection for ethical manufacturers who follow quality standards.
This is how India can build trust for patients, hospitals, insurers and global partners.
Real‑World Evidence: The Missing Ingredient in Indian Healthcare
India still lacks long‑term data on how implants perform in Indian patients. A registry will finally answer critical questions:
- Which orthopaedic implants last longest in Indian bone structures?
- Which cardiac devices work best for diabetic populations?
- Which implants lead to fewer revision surgeries?
This evidence will strengthen PM‑JAY reimbursement, Health Technology Assessments (HTA), procurement decisions and insurance pricing. Better data means better care and lower costs.
The Economic Case: The Registry Pays for Itself
Revision surgeries due to implant failure cost patients and the health system hundreds of crores every year. Early detection of safety issues can prevent a significant portion of these surgeries. The savings alone can fund the registry many times over.
This is not an expense. It is an investment in safer, more affordable healthcare.
A Practical Path Forward
The Ministry of Health & Family Welfare and CDSCO can establish the National Implant Registry under the Materiovigilance Programme of India (MvPI). A phased approach is realistic:
- Start with Class D high‑risk implants (cardiac, orthopaedic, neurovascular).
- Integrate with UDI databases and ABHA IDs.
- Expand gradually to other implant categories.
- Ensure patient privacy through anonymised analytics.
India already has the digital infrastructure and industry readiness to make this happen.
A Call to Action
Civil society, patient‑rights groups and policymakers share a common goal: safer, more transparent healthcare. A National Implant Registry is not a bureaucratic exercise; it is a moral commitment to every Indian patient.
You cannot improve what you do not measure. India must act now to ensure that what goes inside the human body is traceable, accountable and continuously monitored.
A National Medical Implant Registry is not just a reform. It is a promise of safety, dignity and trust for a truly Viksit Bharat.
